Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PBBI
6226
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $2K | ﹤0.01% |
189
-10
| -5% | -$104 |
2016 Q1
6 quarters
|
|
|
MNI
6227
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $2K | ﹤0.01% |
360
+350
| +3,500% | +$2.68K |
2013 Q2
17 quarters
|
|
|
IDXG
6228
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $2K | ﹤0.01% |
100
-716
| -88% | -$8.45K |
2016 Q4
3 quarters
|
|
|
ADYX
6229
DELISTED
Adynxx Inc
ADYX
| $2K | ﹤0.01% |
91
-22
| -19% | -$455 |
2014 Q1
14 quarters
|
|
|
SNMX
6230
DELISTED
Senomyx, Inc.
SNMX
| $2K | ﹤0.01% |
3,120
-2,180
| -41% | -$1.51K |
2013 Q2
17 quarters
|
|
|
DBBR
6231
DELISTED
Xtrackers MSCI Brazil Hedged Equity ETF
DBBR
| $2K | ﹤0.01% |
165
-3
| -2% | -$34 |
2013 Q4
15 quarters
|
|
|
VIIX
6232
DELISTED
VelocityShares VIX Short Term ETN
VIIX
| $2K | ﹤0.01% |
+20
| New | +$1.96K |
2017 Q3
0 quarters
|
|
|
TEAR
6233
DELISTED
TearLab Corporation
TEAR
| $2K | ﹤0.01% |
1,701
| – | – |
2013 Q4
15 quarters
|
|
|
CYTR
6234
DELISTED
CytRx Corp
CYTR
| $2K | ﹤0.01% |
1,039
-35,087
| -97% | -$119K |
2013 Q4
15 quarters
|
|
|
PGM
6235
DELISTED
iPath Bloomberg Platinum Subindex Total Return ETN due June 24, 2038
PGM
| $2K | ﹤0.01% |
100
| – | – |
2016 Q3
4 quarters
|
|
6236
DELISTED
Global X Brazil Mid Cap ETF
BRAZ
| $2K | ﹤0.01% |
200
-25,052
| -99% | -$275K |
2013 Q4
15 quarters
|
|
6237
DELISTED
Affinity Bancshares
AFBI
| $1K | ﹤0.01% |
+40
| New | +$578 |
2017 Q3
0 quarters
|
|
6238
Arts-Way Manufacturing Co
ARTW
$18.4M
| $1K | ﹤0.01% |
679
+79
| +13% | +$198 |
2014 Q1
14 quarters
|
|
6239
Avino Silver & Gold Mines
ASM
$943M
| $1K | ﹤0.01% |
435
| – | – |
2016 Q4
3 quarters
|
|
6240
Broadway Financial
BYFC
$106M
| $1K | ﹤0.01% |
54
| – | – |
2013 Q4
15 quarters
|
|
6241
Cemtrex
CETX
$3.53M
| – | – |
0
| – | – |
2015 Q2
9 quarters
|
|
6242
Pacer US Cash Cows 100 ETF
COWZ
$19.1B
| $1K | ﹤0.01% |
+40
| New | +$1.06K |
2017 Q3
0 quarters
|
|
6243
Citius Pharmaceuticals
CTXR
$13.7M
| $1K | ﹤0.01% |
+8
| New | +$624 |
2017 Q3
0 quarters
|
|
6244
eGain
EGAN
$139M
| $1K | ﹤0.01% |
400
-7,000
| -95% | -$13.6K |
2016 Q1
6 quarters
|
|
6245
Euroseas
ESEA
$503M
| $1K | ﹤0.01% |
100
-4,120
| -98% | -$38.6K |
2013 Q4
15 quarters
|
|
6246
Global X FinTech ETF
FINX
$159M
| $1K | ﹤0.01% |
+60
| New | +$1.19K |
2017 Q3
0 quarters
|
|
6247
Amplify Video Game Tech ETF
GAMR
$41.5M
| $1K | ﹤0.01% |
+17
| New | +$730 |
2017 Q3
0 quarters
|
|
6248
Gilat Satellite Networks
GILT
$689M
| $1K | ﹤0.01% |
89
-441
| -83% | -$2.48K |
2017 Q2
1 quarter
|
|
6249
DELISTED
Glen Burnie Bancorp
GLBZ
| $1K | ﹤0.01% |
67
-400
| -86% | -$4.29K |
2013 Q4
15 quarters
|
|
6250
Crescent Biopharma
CBIO
$554M
| $1K | ﹤0.01% |
1
-75
| -99% | -$88K |
2015 Q1
10 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.